Effect of in ovo ghrelin administration on serum malondialdehyde level in newly-hatched chickens

来源 :亚太热带生物医学杂志(英文版) | 被引量 : 0次 | 上传用户:TSNT1234
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To investigate effects of in ovo ghrelin administration on serum malondialdehyde (MDA) level in newly-hatched chickens. Methods: Fertilized eggs were divided into 7 groups: group T1 as control (without injection), group T2 (in ovo injected with 50 ng/egg ghrelin on day 5), group T3 (in ovo injected with 100 ng/egg ghrelin on day 5), group T4 (in ovo injected with 50 ng/egg ghrelin on day 10), group T5 (in ovo injected with 100 ng/egg ghrelin on day 10), group T6 (in ovo injected with solvent: 1% acetic acid, without ghrelin on day 5) and group T7 (in ovo injected with solvent without ghrelin on day 10). After hatching, serum MDA concentrations were determined. Results:Ghrelin administrated groups (T2, T3, T4 and T5) had lower serum MDA level in comparison with control group (T1) or solvent injected groups (T6 and T7). T2 and T3 (ghrelin injection on day 5) had significantly lower MDA concentrations (4.10 and 4.60 nmol/mL, respectively) in comparison with other groups. In T4 and T5, MDA levels were lower than T1, T6 and T7 (non-ghrelin administrated groups) (9.53 and 9.50 in comparison with 10.73, 10.03 and 10.13 nmol/mL) and were higher than T2 and T3. Conclusions: It can be concluded that in ovo administration of ghrelin can have anti-oxidative protection and reduce serum MDA level. Ghrelin administration on day 5 of incubation is more efficient.
其他文献
期刊
目的 对糖尿病患者应用药学服务对其血糖控制情况以及用药依从性进行观察与分析.方法 选取我院2017年1月~2018年3月期间我院收治的糖尿病患者90例,随机分为观察组和对照组,每
艾曲波帕作为一种人体血小板生成素受体激动剂,用于治疗血小板减少和重型再生障碍性贫血,近年其在去铁方面突显出巨大优势,它通过调节体内葡萄糖醛酸化代谢,在机体内的铁与肝脏共轭之前将其从粪便和尿液中排除,从而有效降低人体内的过载铁。
期刊
期刊
@@
2005年Baveno Ⅳ工作组讨论了门脉高压静脉曲张出血相关的一些定义和标准、门脉高压治疗的选择、今后研究的方法学要求等,所达成的共识意见和所依赖的证据均用循证医学Oxford
目的 分析功能性视力不良患者集合功能、调节功能特点,研究双眼视觉训练对功能性视力不良患者的疗效.方法 回顾性研究.收集2012年7月至2013年10月于天津市眼科医院视光中心视
期刊
目的 探讨孟鲁司特对慢性阻塞性肺疾病患者外血Th17相关细胞因子表达的影响.方法 按随机数字表法将2017年1月至2019年1月就诊于我院的90例慢性阻塞性肺疾病患者分为两组,各45